Grant and Funding Programs Offered by Canadian Blood Services (CBS)

Canadian Blood Services is a national, not-for-profit health organization that manages Canada’s blood system (excluding Quebec) and plays a central role in transfusion and transplantation medicine. It oversees the collection, testing and distribution of blood, plasma and platelets, operates stem cell programs including a national registry and public cord blood bank, and supports organ and tissue donation and transplantation services. The organization ensures that hospitals across the country have a secure and sustainable supply of life‑essential products.

Beyond its operational role, Canadian Blood Services is an important research funder in transfusion science, cellular therapies and organ and tissue transplantation. Through its Centre for Innovation, the organization offers multiple competitive funding programs open to Canadian researchers whose projects align with Canadian Blood Services priorities. These programs support discovery research, clinical studies, product and process development, and knowledge translation activities that enhance patient care and system safety.

The research portfolio spans the full translational continuum, from basic laboratory work to bedside implementation. Funded projects address issues such as blood component quality, donor and recipient safety, emerging pathogens, novel cellular therapies, and optimization of organ and tissue utilization. In addition to direct research grants, Canadian Blood Services builds capacity through training and education, supporting trainees and collaborations within an extended network of academic and clinical partners. Results are disseminated via peer‑reviewed publications, progress reports, accessible research summaries and the RED research, education and discovery blog.

Canadian Blood Services’ funding opportunities primarily target Canadian investigators and teams in universities, hospitals and research institutes who are working on questions relevant to the national blood, plasma, stem cell, and organ and tissue systems. By investing in innovation and evidence‑based practices, the organization helps improve clinical outcomes, strengthens health system performance and supports long‑term security of Canada’s lifeline for patients who depend on transfusion and transplantation therapies.

The organization operates with funding from provincial, territorial and federal governments and works closely with hospital partners, clinicians and public health agencies. It emphasizes transparency through public reports and publications and adheres to stringent regulatory and licensing requirements for all production and distribution sites. This governance framework underpins both its service delivery and its role as a steward of research funds dedicated to improving care for patients across Canada.